HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.

Khurana, Surender.Norris, Philip J.Busch, Michael P.Haynes, Barton F.Park, Susan.Sasono, Pretty.Mlisana, Koleka Patience.Abdool Karim, Salim Safurdeen.Hecht, Frederick M.Mulenga, Joseph.Chomba, Elwyn.Hunter, Eric.Allen, Susan.Nemo, George.Rodriguez-Chavez, Isaac R.Women’s Interagency HIV Study Collaborative Study Group.Margolick, Joseph B.Golding, Hana.2012-11-282012-11-2820092009Khurana, S. et al. 2010. HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection. J Clin Microbiol. 48(1), pp. 281–285.0095-1137http://dx.doi.org/10.1128/JCM.01573-09http://hdl.handle.net/10413/8031HIV-Selectest is a serodiagnostic enzyme immunoassay (EIA), containing p6 and gp41 peptides, designed to differentiate between vaccine-induced antibodies and true infections. A rapid test version of the HIV-Selectest was developed. Both assays detected HIV antibodies in men and women within 2 to 4 weeks of infection, with sensitivity similar to third-generation EIAs.enHIV (Viruses)HIV infections--Immunology.HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.Peer reviewed journal article